Actinium Pharmaceuticals Appoints Sandesh Seth as Principal Financial Officer
Position
Principal Financial Officer
Company
Actinium Pharmaceuticals
New YorkBiotechnologyHealth CareTherapeuticsDescription
On February 13, 2026, Actinium Pharmaceuticals, Inc appointed Sandesh Seth as the principal financial officer following the resignation of Steve O’Loughlin. Mr O’Loughlin's resignation is effective February 27, 2026, as he pursues other opportunities. Mr Seth has been serving as the CEO of the company since June 2017.
Quick answer
Actinium Pharmaceuticals Appoints Sandesh Seth as Principal Financial Officer (February 13, 2026). Actinium Pharmaceuticals is based in New York, New York, United States.
- Who is the new Principal Financial Officer at Actinium Pharmaceuticals?
- Actinium Pharmaceuticals named Sandesh Seth Principal Financial Officer, announced February 13, 2026.
- What did Actinium Pharmaceuticals announce on February 13, 2026?
- On February 13, 2026, Actinium Pharmaceuticals, Inc appointed Sandesh Seth as the principal financial officer following the resignation of Steve O’Loughlin. Mr O’Loughlin's resignation is effective February 27, 2026, as he pursues other opportunities.
- What does Actinium Pharmaceuticals do?
- Actinium Pharmaceuticals (NYSE: ATNM) is focused on developing innovative targeted radioimmunotherapies for the treatment of advanced cancers.
- Where is Actinium Pharmaceuticals based?
- Actinium Pharmaceuticals is based in New York, New York, United States.
- Which similar companies made leadership changes around the same time?
- Lahjavida Bio (February 13, 2026), Cue Biopharma (February 12, 2026), Verrica (February 12, 2026) and Arvinas (February 12, 2026) also announced leadership changes within 45 days of Actinium Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Lahjavida Bio Appoints Stephen LaMond as Chief Operating Officer (February 13, 2026)
- Cue Biopharma Appoints Lucinda Warren as Chief Financial and Business Officer (February 12, 2026)
- Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer (February 12, 2026)
- Briggs Morrison Appointed as New CEO of Arvinas, Inc. (February 12, 2026)
- BOOST Pharma Appoints Hans Schambye as Chief Executive Officer (February 10, 2026)
- FYR Bio Appoints Barbara K. Zehentner as Chief Operating Officer (February 10, 2026)
Who to call at Actinium Pharmaceuticals, and when
A new leader at Actinium Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Actinium Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Actinium Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Actinium Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Actinium Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Actinium Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.